Astellas Pharma Ltd. today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorization for PADCEV™ (enfortumab vedotin, an...
Combination
News ReleaseThursday, June 20, 2024 Combination therapy developed by NIH researchers demonstrates the power of precision medicine.Researchers at the National...
